ABSTRACT
Background and Aims Generative Pre-trained Transformer-4 (GPT-4) is a large language model (LLM) trained on a variety of topics, including the medical literature. Nutrition plays a critical role in managing inflammatory bowel disease (IBD), with an unmet need for nutrition-related patient education resources. The aim of this study is to examine the accuracy and reproducibility of responses by GPT-4 to patient nutrition questions related to IBD.
Methods Questions were curated from adult IBD clinic visits, Facebook, and Reddit. Two IBD-focused registered dieticians independently graded the accuracy and reproducibility of GPT-4’s responses while a third senior IBD-focused registered dietitian arbitrated. To ascertain reproducibility, each question was inputted twice into the model. Descriptive analysis is presented as counts and proportions.
Results In total, 88 questions were included. The model provided correct responses to 73/88 questions (83.0%), with 61 (69.0%) graded as comprehensive. A total of 15/88 (17%) responses were graded as mixed with correct and incorrect/outdated data. When examined by category, the model provided comprehensive responses to 10 (62.5%) questions related to “Nutrition and diet needs for surgery”, 12 (92.3%) “Tube feeding and parenteral nutrition”, 11 (64.7%) “General diet questions”, 10 (50%) “Diet for reducing symptoms/inflammation” and 18 (81.8%) “Micronutrients/supplementation needs”. The model provided reproducible responses to 81/88 (92.0%) questions.
Conclusion GPT-4 provided comprehensive responses to the majority of questions, demonstrating the promising potential of LLMs as supplementary tools for IBD patients seeking nutrition-related information. However, 17% of responses contained incorrect information, highlighting the need for continuous refinement and validation of LLMs prior to incorporation into clinical practice. Future studies should focus on leveraging LLMs to enhance patient outcomes. Furthermore, efforts promoting patient and healthcare professional proficiency in using LLMs are essential to maximize their efficacy and facilitate personalized care.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Update the abstract of the manuscript as well as capitalize first authors first name.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
